<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="retraction" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1491753</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2024.1491753</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Retraction: NR2F1-AS1/miR-190a/PHLDB2 induces the epithelial&#x2013;mesenchymal transformation process in gastric cancer by promoting phosphorylation of AKT3</article-title>
<alt-title alt-title-type="left-running-head">Frontiers Editorial Office</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2024.1491753">10.3389/fcell.2024.1491753</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<collab>Frontiers Editorial Office</collab>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/228891/overview"/>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Approved by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/56085/overview">Frontiers Editorial Office</ext-link>, Frontiers Media SA, Switzerland</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Frontiers Editorial Office, <email>research.integrity@frontiersin.org</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>09</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>1491753</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>09</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>09</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Frontiers Editorial Office.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Frontiers Editorial Office</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="retracted-article" journal-id="Front. Cell Dev. Biol." journal-id-type="nlm-ta" xlink:href="10.3389/fcell.2021.688949" ext-link-type="doi">A retraction of the Original Research Article <article-title>NR2F1-AS1/miR-190a/PHLDB2 induces the epithelial&#x2013;mesenchymal transformation process in gastric cancer by promoting phosphorylation of AKT3</article-title> by Lv J, Zhang S, Liu Y, Li C, Guo T, Zhang S, Li Z, Jiao Z, Sun H, Zhang Y, and Xu L (2021). Front. Cell Dev. Biol. 9:688949. doi: <object-id>10.3389/fcell.2021.688949</object-id>
</related-article>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Molecular and Cellular Oncology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>The journal retracts the 22 October 2021 article cited above.</p>
<p>Following publication, Frontiers was alerted to the presence of non-verifiable cell line identifiers in this publication. Upon further examination, it was determined that core findings of this study were obtained using non-verifiable cell lines and/or cell lines known to be cross-contaminated with HeLa. This contamination compromises the data and conclusions of the article and the article has been retracted.</p>
<p>This retraction was approved by the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and have not responded to the retraction. This communication has been recorded by the publisher.</p>
</body>
</article>